INFLECTION POINT ACQUISITION CORP. IV 8-K

What Happened
Inflection Point Acquisition Corp. IV (f/k/a Bleichroeder Acquisition Corp. I) held an Extraordinary General Meeting on March 12, 2026 and announced that shareholders approved the proposed business combination with Merlin Labs, Inc. (Business Combination Agreement dated August 13, 2025). The meeting quorum was 20,358,101 shares (60.31%) based on the Feb. 2, 2026 record date; the Business Combination and related proposals (domestication, charter/bylaws, stock issuances, director elections and equity plans) were all approved.

Key Details

• Meeting/record dates: Extraordinary General Meeting on March 12, 2026; record date Feb. 2, 2026. Quorum: 20,358,101 shares (60.31%).
• Business Combination vote: FOR 18,540,948; AGAINST 1,811,622; ABSTAIN 5,531. Merger Sub will merge into Merlin, leaving Merlin OpCo as a wholly owned subsidiary of Inflection Point upon closing.
• Domestication (Cayman → Delaware) by Class B holders approved: FOR 8,333,333 (no votes against/abstentions reported). Upon effectiveness, Inflection Point will re-domicile as a Delaware corporation and outstanding securities will convert to New Merlin securities.
• Organizational and governance approvals: Proposed Charter and Bylaws approved; advisory votes approved (including authorization of 850,000,000 common shares and 50,000,000 preferred shares, adoption of exclusive forum provisions, two‑thirds vote provisions, prohibition on action by written consent, and corporate name change to Merlin, Inc.).
• Board and equity plans: Seven directors were elected (Matt George; Michael Blitzer; Kenneth Braithwaite; Kelyn Brannon; Michael Montelongo; Carolyn Trabuco; Dr. Robert H. Smith). New Merlin 2026 Incentive Award Plan and 2026 Employee Stock Purchase Plan were approved (Incentive Plan: FOR 18,520,621; ESPP: FOR 18,527,373).

Why It Matters
These approvals clear key shareholder hurdles for the proposed business combination and corporate re-domiciliation. If and when the transaction closes, Merlin will operate as the primary operating subsidiary of the combined company (to be re-domiciled as Delaware “Merlin, Inc.”), the board slate and long‑term incentive/ESPP frameworks will be in place, and share-authorizations required for issuing stock and complying with Nasdaq rules have been approved — all important governance and structural steps ahead of closing. This 8‑K reports completed shareholder votes; consummation remains subject to the conditions in the Business Combination Agreement and required filings.